Xalatan and Glaucoma - a phase IV clinical study of FDA data
Summary:
Glaucoma is found among people who take Xalatan, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Xalatan and have Glaucoma. It is created by eHealthMe based on reports of 24,860 people who have side effects when taking Xalatan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
24,860 people reported to have side effects when taking Xalatan.
Among them, 1,330 people (5.35%) have Glaucoma.
What is Xalatan?
Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 24,707 Xalatan users for its effectiveness, alternative drugs and more.
What is Glaucoma?
Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 2,353 drugs and 1,596 conditions by eHealthMe.
Number of Xalatan and Glaucoma reports submitted per year:

Time on Xalatan when people have Glaucoma *:
Gender of people who have Glaucoma when taking Xalatan*:
Age of people who have Glaucoma when taking Xalatan *:
Common drugs people take besides Xalatan *:
Common side effects people have besides Glaucoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xalatan and have Glaucoma?
Check whether Glaucoma is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Related studies
How severe was Glaucoma and when was it recovered:
Expand to all the drugs that have ingredients of latanoprost:
- Glaucoma and drugs with ingredients of latanoprost (1,849 reports)
Alternative drugs to, pros and cons of Xalatan:
- Xalatan (24,707 reports)
Common Xalatan side effects:
- Drug ineffective: 1,490 reports
- Cataract (clouding of the lens inside the eye): 1,359 reports
- Glaucoma (increased fluid pressure in the eye with vision loss): 1,330 reports
- High blood pressure: 1,187 reports
- Dizziness: 1,025 reports
- Breathing difficulty: 1,005 reports
Browse all side effects of Xalatan:
a b c d e f g h i j k l m n o p q r s t u v w x y zGlaucoma treatments and more:
- Glaucoma (55,776 reports)
COVID vaccines that are related to Glaucoma:
- Glaucoma in Moderna COVID Vaccine
- Glaucoma in Pfizer BioNTech Covid Vaccine
- Glaucoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Glaucoma:
- Prednisone: 1,683 reports
- Humira: 1,474 reports
- Methotrexate: 1,355 reports
- Xalatan: 1,330 reports
- Enbrel: 1,183 reports
- Aspirin: 1,155 reports
- Fosamax: 840 reports
- Metformin: 759 reports
- Lipitor: 743 reports
- Lyrica: 678 reports
All the drugs that are associated with Glaucoma:
- Glaucoma (2,353 drugs)
Common conditions associated with Glaucoma:
- Rheumatoid arthritis: 2,071 reports
- High blood pressure: 1,507 reports
- Osteoporosis: 1,029 reports
- Diabetes: 838 reports
- High blood cholesterol: 825 reports
All the conditions that are associated with Glaucoma:
- Glaucoma (1,596 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Angioneurotic Oedema Aggravated and drugs of ingredients of methylprednisolone sodium succinate - 3 seconds ago
- Adalat Cc vs. Esidrix - 25 seconds ago
- Gabapentin and Hyperaesthesia - 25 seconds ago
- Furosemide and Blood Creatinine Increased - 26 seconds ago
- Cyproheptadine Hydrochloride vs. Riboflavin - 29 seconds ago
- Pain and Hyperaesthesia - 31 seconds ago
- Leuprolide Acetate and Prostate Cancer - 41 seconds ago
- Activities Of Daily Living Impaired and drugs of ingredients of leflunomide - 55 seconds ago
- Rhabdomyolysis and drugs of ingredients of clonazepam - 57 seconds ago
- Hyperaesthesia and pfizer biontech covid vaccine - 59 seconds ago